Published: 2020-04-21

Skin adnexal tumors: a 5 years single institutional experience

Subbiah Shanmugam, Jagadish Singh Alluru, Samanth Kumar Mendu


Background: Skin tumors comprise of innumerable benign and malignant lesions. They vary in behaviour and malignant potential. Apart from more common melanomatous and squamous cell carcinomas, there exist unexplored arena of adnexal tumors that are rare and most often pose a dilemma for treating doctor. Their demography and presentation are yet to be standardized globally.

Methods: This is a cross-sectional descriptive study undertaken in department of surgical oncology, government Royapettah hospital, Chennai from January 2013 to 2019, primarily focused to analyze the various cutaneous adnexal tumors with regard to age, sex, site, size, behavior, origin of these tumors and to correlate with the clinical presentation. Descriptive characteristics like frequencies were computed for categorical variables like gender, histologic diagnosis, primary site of disease, and type of surgical treatment, while numeric variables were summarized using mean with standard deviation, median and range.

Results: Thirteen cutaneous adnexal lesions were reported in the past 5 years at our institute. Out of the 13 cases two were benign and eleven were of malignant skin adnexal tumors. Sweat gland tumors were the most common tumors encountered and were found to be more common in males below age of 60, trunk being common site of occurrence.

Conclusions: One should have high index of suspicion, aided by proper histopathology followed by aggressive treatment is necessary for proper control. Most of them need adjuvant treatment. No standardized treatment poses some problem, that needs to be addressed with proper documentation.


Skin adnexal tumors, Porocarcinoma, Eccrine, Apocrine, Chemotherapy

Full Text:



Martinez SR, Barr KL, Canter RJ. Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors. Arch Dermatol. 2011;147:1056-62.

Boit LPE, editor. Pathology and genetics of skin tumors. IARC; 2006.

Deo SV, Hazarika S, Shukla NK, Kumar S, Kar M, Samaiya A. Surgical management of skin cancers: Experience from a regional cancer centre in North India. Indian J Cancer. 2005;42(3).

Blake PW, Bradford PT, Devesa SS, Toro JR. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. Arch Dermatol. 2010;146:625-32.

Avraham JB, Villines D, Maker VK, August C, Maker AV. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes. J Surg Oncol. 2013;108:57-62.

Chiller K, Passaro D, Scheuller M, Singer M, Calmont MT, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol. 2000;136:1355-9.

Dores GM, Huycke MM, Devesa SS, Garcia CA. Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005. J Am Acad Dermatol. 2010;63:71-8.

Jurcic V, Kukovic J, Zidar N. Expression of desmosomal proteins in acantholytic squamous cell carcinoma of the skin. Histol Histopathol. 2015;30:945-53.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21:43-52.

Guerriero S, Ruffolo C, Lombardi AR, Tirone A, Tirone G. Recurrent pleural effusion and pulmonary metastases from a cutaneous apocrine tumour of the axilla. Acta Chir Belg. 2007;107:697-9.

Carre GM, Weill F, Mamelle G, Kolb F, Boitier F, Petrow P, et al. Microcystic adnexal carcinoma: report of seven cases including one with lung metastasis. JAMA Dermatol. 2006;212:221-8.

Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158-65.

Ogata D, Kiyohara Y, Yoshikawa S, Kasami M. Treatment strategy for cutaneous apocrine carcinoma. Int J Clin Oncol. 2014;19:712-5.

Romeu M, Foletti JM, Chossegros C, Dales JP, Berbis P, Cribier B, et al. Malignant cutaneous adnexal neoplasms of the face and scalp: diagnostic and therapeutic update. J Stomatol Oral Maxillofac Surg. 2017;118:95-102.

Battistella M, Mateus C, Lassau N, Chami L, Boukoucha M, Duvillard P, et al. Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma. J Eur Acad Dermatol Venereol. 2010;24:199-203.

Piedbois P, Breau JL, Morere JF, Israel L. Sweat gland carcinoma with bone and visceral metastases. Prolonged complete remission lasting 16 months as a result of chemotherapy. Cancer. 1987;60:170-2.

Iuliis DF, Amoroso L, Taglieri L, Vendittozzi S, Blasi L, Salerno G, et al. Chemotherapy of rare skin adnexal tumors: a review of literature. Anticancer research. 2014;34:5263-8.

Oyasiji T, Tan W, Kane J, Skitzki J, Francescutti V, Salerno K, et al. Malignant adnexal tumors of the skin: a single institution experience. World J Surg Oncol. 2018;16:99.